1075230-69-1

Basic information

• Product Name: (S)-4-(5-amino-2-fluorophenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine
• Synonyms: (S)-4-(5-amino-2-fluorophenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine
• CAS NO: 1075230-69-1
• Molecular Weight: 239.317
• Mol File: 1075230-69-1.mol

Chemical Properties

• CAS DataBase Reference: (S)-4-(5-amino-2-fluorophenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-(5-amino-2-fluorophenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine(1075230-69-1)
• EPA Substance Registry System: (S)-4-(5-amino-2-fluorophenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine(1075230-69-1)

Safety Data

• Hazardous Substances Data: 1075230-69-1(Hazardous Substances Data)

Upstream product

• 1432511-81-3 (S)-ethyl 3-((R)-1,1-dimethylethylsulfinamido)-3-(2-fluorophenyl)butanoate 
• 1606166-80-6 (R)-N-[1-(2-fluorophenyl)ethylidene]-2-methyl-propane-2-sulfinamide 
• 1336669-71-6 (S)-3-amino-3-(2-fluoro-5-nitrophenyl)butan-1-ol 
• 1075230-68-0 C₁₁H₁₂FN₃O₂S*ClH 

Downstream Products

• 1334551-57-3 C₂₁H₂₅FN₄O₃S 
• 1076188-86-7 C₁₆H₁₇ClFN₅OS 
• 1076189-11-1 (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-fluoropicolinamide 
• 1076109-53-9 C₁₉H₁₈FN₅OS 
• 1076189-08-6 C₁₈H₁₆F₄N₄OS 
• 1076188-82-3 C₁₆H₁₈FN₅OS 
• 1075230-13-5 (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide 
• 1271948-76-5 (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-chloropicolinamide 
• 1075223-48-1 (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(2,2,2-trifluoroethoxy)pyrazine-2-carboxamide 
• 1076188-75-4 (S)-N-(3-(2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide 
• 1301740-83-9 C₁₅H₁₆FN₅S 
• 1301740-81-7 C₁₆H₁₇FN₄S 
• 1301740-82-8 C₁₅H₁₆FN₅S 

Relevant articles and documents

Trifluoromethyl Dihydrothiazine-Based β-Secretase (BACE1) Inhibitors with Robust Central β-Amyloid Reduction and Minimal Covalent Binding Burden

The β-site amyloid precursor protein cleaving enzyme 1 (BACE1, also known as β-secretase) is a promising target for the treatment of Alzheimer's disease. A pKa lowering approach over the initial leads was adopted to mitigate hERG inhibition and

AMINODIHYDROTHIAZINE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUPS

This invention provides a compound of the formula (I): wherein the ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; R1 is optionally substituted lower alkyl, optionally substituted lower alk

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALZHEIMER'S DISEASE

A pharmaceutical composition for treating Alzheimer's disease containing a compound represented by the general formula (I): wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; E is lower alkylene,